Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Pharma
The Oral GLP-1 Tracker: Novo’s Wegovy keeps gaining ground
Fierce Pharma's weekly Oral GLP-1 Tracker monitors prescription trends for Novo Nordisk's Wegovy pill and Eli Lilly's Foundayo.
Angus Liu
,
Kevin Dunleavy
,
Fraiser Kansteiner
Jun 12, 2026 2:30pm
Lilly, Biogen, Eisai and Genentech sponsor Alzheimer’s podcast
Jun 12, 2026 9:09am
Novo Nordisk’s ‘optimistic’ CEO Doustdar sits down with Fierce
Jun 11, 2026 7:00am
Lilly yells ‘action’ on authentic patient portrayals at Tribeca
Jun 10, 2026 5:30pm
ADA: Lilly's Foundayo pads case against semaglutide in diabetes
Jun 8, 2026 3:42pm
Eli Lilly is the ‘clear winner’ from ADA, RBC analyst says
Jun 8, 2026 3:12pm
